Stock Overview
Insmed Inc (INSM)
NASDAQ · Healthcare · Biotechnology
Insmed Inc is a Healthcare company with a market capitalization of $22.41B.
Market Cap
$22.41B
Forward P/E
16.4
Price/Sales
27.3
Price/Book
31.8
EV/EBITDA
-6.1
Beta
0.77
EPS (TTM)
$-5.76
Profit Margin
-144.4%
ROE
-294.5%
52W High
$212.75
52W Low
$90.39
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Revenue
$606.42M
Gross Profit
$481.55M
Operating Income
-$1.18B
Net Income
-$1.28B
Free Cash Flow
-$967.58M
Total Debt
$560.23M
Cash & Equivalents
$510.44M
Shareholder Equity
$738.98M
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 7, 2026 | $-0.76 | $-1.00 | +24.0% |
| Q4 2025 | February 19, 2026 | $-1.54 | $-1.17 | -31.6% |
| Q3 2025 | October 30, 2025 | $-1.75 | $-1.37 | -27.7% |
| Q2 2025 | August 7, 2025 | $-1.70 | $-1.31 | -29.8% |
| Q1 2025 | May 8, 2025 | $-1.42 | $-1.20 | -18.3% |
| Q4 2024 | February 20, 2025 | $-1.32 | $-1.23 | -7.3% |
Other Biotechnology Stocks
Frequently Asked Questions
What is Insmed Inc's market cap?
As of June 29, 2026, Insmed Inc (INSM) has a market capitalization of $22.41B.
Does Insmed Inc pay a dividend?
Insmed Inc does not currently pay a dividend.
What sector is INSM in?
Insmed Inc is in the Healthcare sector, specifically the Biotechnology industry.
What was Insmed Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Insmed Inc reported revenue of $606.42M and net income of -$1.28B.
Ask your own questions about INSM
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.